Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial Liquid
NCT ID: NCT05678049
Last Updated: 2023-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2023-01-15
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to use this liquid for Microscopic and Spectrophotometric evaluation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Glucosamine on Joint Fluid in Osteoarthritis Patients
NCT01074476
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.
NCT01233739
Ultrasonication-mediated Microbubbles Dressing for Hand Arthritis
NCT06913088
A Multicentre Clinical Investigation to Assess Efficacy and Safety of Intra-articular Injections of Hyaluronic Acid Combined With Chondroitin Sulfate in Knee Osteoarthritis
NCT04358120
Efficiency and Usability of the Iontophoretic Patch Feeligreen Diclofenac in Treating Acute Osteoarthritic Knee Pain
NCT02784691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Synovial fluid analysis
For patients with knee under tension at the joint level, the symptomatology often requires evacuation by puncture under ultrasound guidance. The intervention will be performed only for patients for whom this therapeutic indication exists anyway by their physicians.
After making the evacuation we will want to use this liquid for Microscopic and Spectrophotometric evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>18 years
Exclusion Criteria
-age\<18 years
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iuliu Hatieganu University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ciubean Alina Deniza
Director
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMFCluj
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.